RG

Robert D. Groneberg

AB Array Biopharma: 13 patents #53 of 335Top 20%
AG Aventis Pharma Deutschland Gmbh: 2 patents #137 of 418Top 35%
AP Aventis Pharmaceuticals: 2 patents #139 of 454Top 35%
AM Amgen: 2 patents #1,289 of 2,867Top 45%
VP Ventirx Pharmaceuticals: 2 patents #9 of 18Top 50%
RP Rhone-Poulenc Rorer Pharmaceuticals: 1 patents #68 of 155Top 45%
SA Sanofi-Aventis: 1 patents #630 of 1,008Top 65%
SR Scripps Research: 1 patents #709 of 1,293Top 55%
AP Aventis Pharmaceuticals Products: 1 patents #25 of 76Top 35%
Overall (All Time): #209,535 of 4,157,543Top 6%
21
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
9242964 Substituted benzoazepines as toll-like receptor modulators James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, George A. Doherty +2 more 2016-01-26
8962596 5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases Laurence E. Burgess, Mark Laurence Boys, Darren Harvey, Timothy Kercher, Christopher F. Kraser +4 more 2015-02-24
8809538 Piperidine-containing compounds and use thereof Martha E. Rodriguez, David A. Mareska, Jeremy Hans, Darren Harvey, Michael O'Sullivan 2014-08-19
8524702 Substituted benzoazepines as toll-like receptor modulators James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, George A. Doherty +2 more 2013-09-03
8304407 8-substituted benzoazepines as toll-like receptor modulators George A. Doherty, Charles Todd Eary, Zachary Jones 2012-11-06
8153622 8-substituted benzoazepines as toll-like receptor modulators George A. Doherty, C. Todd Eary, Zachary Jones 2012-04-10
8044083 Kinase inhibitors and methods of use thereof Laurence E. Burgess, Darren Harvey, Ellen Laird, Mark Munson, James P. Rizzi +3 more 2011-10-25
8039639 Kinase inhibitors and methods of use thereof Laurence E. Burges, Darren Harvey, Ellen Laird, Mark Munson, James P. Rizzi +3 more 2011-10-18
7612075 Substituted oxoazaheterocyclyl compounds William R. Ewing, Michael R. Becker, Yong Mi Choi-Sledeski, Heinz W. Pauls, Wei He +16 more 2009-11-03
7521447 P38 inhibitors and methods of use thereof Mark Munson, David A. Mareska, Youngboo Kim, James P. Rizzi, Martha E. Rodriguez +5 more 2009-04-21
RE40558 Therapeutic uses of di-aryl acid derivatives Zaid Jayyosi, Gerard McGeehan, Michael Kelley, Richard F. Labaudiniere, Litao Zhang +4 more 2008-10-28
7425631 Compounds and methods of use Benny C. Askew, Jr., Derin D'Amico, James Zhan, Andras Toro, Youngboo Kim +14 more 2008-09-16
7199244 Cyclic amine derivatives and methods of use James Zhan, Benny C. Askew, Jr., Derin D'Amico, Nianhe Han, Christopher H. Fotsch +6 more 2007-04-03
7078425 Preparation of phosphatase inhibitors David A. Mareska 2006-07-18
7005440 Therapeutic uses of tri-aryl acid derivatives Zaid Jayyosi, Gerard McGeehan, Michael Kelley, Richard F. Labaudiniere, Litao Zhang +5 more 2006-02-28
6639023 Fluorophenyl resin compounds Joseph M. Salvino, John E. Airey, Gregory Bernard Poli, Gerard McGeehan, Richard F. Labaudiniere +2 more 2003-10-28
6635655 Therapeutic uses of di-aryl acid derivatives Zaid Jayyosi, Gerard McGeehan, Michael Kelley, Richard F. Labaudiniere, Litao Zhang +4 more 2003-10-21
6586467 Preparation of phosphatase inhibitors Laurence E. Burgess, John Gaudino, Mark H. Norman, Martha E. Rodriguez, Xicheng Sun +1 more 2003-07-01
6306873 Substituted .beta.-thiocarboxylic acids Christopher J. Burns, Richard F. Labaudiniere, Stephen M. Condon, Rose Mathew, Joseph M. Salvino 2001-10-23
6057369 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds Kent W. Neuenschwander, Stevan W. Djuric, Gerald M. McGeehan, Christopher J. Burns, Steven M. Condon +4 more 2000-05-02
5384412 Saccharide intermediates in the formation of the calicheamicin and esperamicin oligosaccharides Kyriacos C. Nicolaou, Erwin Schreiner, Wilhelm Stahl 1995-01-24